Procter & Gamble Company (PG) Stock Forecast, Price Target & Predictions
PG Stock Forecast
Procter & Gamble Company stock forecast is as follows: an average price target of $173.92 (represents a 2.11% upside from PG’s last price of $170.33) and a rating consensus of 'Buy', based on 21 wall street analysts offering a 1-year stock forecast.
PG Price Target
PG Analyst Ratings
Buy
Procter & Gamble Company Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Dec 05, 2024 | Kaumil Gajrawala | Jefferies | $174.00 | $175.69 | -0.96% | 2.15% |
Nov 22, 2024 | Mark Astrachan | Stifel Nicolaus | $167.00 | $176.28 | -5.26% | -1.96% |
Oct 21, 2024 | Bill Chappell | Truist Financial | $180.00 | $169.64 | 6.11% | 5.68% |
Oct 21, 2024 | Nik Modi | RBC Capital | $164.00 | $169.00 | -2.96% | -3.72% |
Oct 21, 2024 | Linda Bolton Weiser | D.A. Davidson | $160.00 | $169.01 | -5.33% | -6.06% |
Oct 21, 2024 | Olivia Tong | Raymond James | $190.00 | $171.28 | 10.93% | 11.55% |
Oct 09, 2024 | Linda Bolton Weiser | D.A. Davidson | $159.00 | $169.27 | -6.07% | -6.65% |
Oct 04, 2024 | Bonnie Herzog | Goldman Sachs | $164.00 | $168.88 | -2.89% | -3.72% |
Sep 30, 2024 | Lauren Lieberman | Barclays | $163.00 | $173.55 | -6.08% | -4.30% |
Sep 23, 2024 | Korinne Wolfmeyer | Piper Sandler | $174.00 | $173.77 | 0.13% | 2.15% |
Sep 16, 2024 | Kevin Grundy | BNP Paribas | $192.00 | $177.02 | 8.46% | 12.72% |
Jul 24, 2024 | Kaumil Gajrawala | Jefferies | $175.00 | $165.93 | 5.47% | 2.74% |
Jul 22, 2024 | Mark Astrachan | Stifel Nicolaus | $161.00 | $167.96 | -4.14% | -5.48% |
Jul 18, 2024 | Robert Ottenstein | Evercore ISI | $183.00 | $169.44 | 8.00% | 7.44% |
Jul 17, 2024 | Steve Powers | Deutsche Bank | $176.00 | $168.53 | 4.43% | 3.33% |
Jun 24, 2024 | Kevin Grundy | BNP Paribas | $187.00 | $168.26 | 11.14% | 9.79% |
Apr 25, 2024 | Chris Graja | Argus Research | $185.00 | $162.88 | 13.58% | 8.61% |
Apr 23, 2024 | Lauren Lieberman | Barclays | $170.00 | $160.54 | 5.89% | -0.19% |
Nov 24, 2023 | Alexia Howard | Bernstein | $40.00 | $151.38 | -73.58% | -76.52% |
Oct 18, 2023 | Dara Mohsenian | Morgan Stanley | $174.00 | $146.26 | 18.97% | 2.15% |
Jan 13, 2023 | Olivia Tong | Raymond James | $170.00 | $150.25 | 13.14% | -0.19% |
Jan 13, 2023 | J.P. Morgan | $150.00 | $149.87 | 0.09% | -11.94% | |
Jan 03, 2023 | Wells Fargo | $168.00 | $150.62 | 11.54% | -1.37% | |
Dec 06, 2022 | Deutsche Bank | $162.00 | $148.47 | 9.11% | -4.89% | |
Nov 16, 2022 | Wells Fargo | $155.00 | $140.49 | 10.33% | -9.00% | |
Nov 15, 2022 | Credit Suisse | $130.00 | $141.66 | -8.23% | -23.68% | |
Oct 12, 2022 | Olivia Tong | Raymond James | $155.00 | $124.43 | 24.57% | -9.00% |
Oct 09, 2022 | Jason English | Goldman Sachs | $143.00 | $124.27 | 15.07% | -16.05% |
Oct 03, 2022 | Wells Fargo | $150.00 | $126.25 | 18.81% | -11.94% | |
Aug 18, 2022 | Lauren Lieberman | Barclays | $154.00 | $149.81 | 2.80% | -9.59% |
Aug 01, 2022 | Truist Financial | $160.00 | $142.60 | 12.20% | -6.06% | |
Jul 21, 2022 | J.P. Morgan | $156.00 | $139.77 | 11.61% | -8.41% | |
Jun 21, 2022 | Deutsche Bank | $157.00 | $135.81 | 15.60% | -7.83% | |
Jun 19, 2022 | Steve Powers | Deutsche Bank | $171.00 | $132.36 | 29.19% | 0.39% |
Jun 06, 2022 | Chris Carey | Wells Fargo | $170.00 | $145.46 | 16.87% | -0.19% |
May 23, 2022 | Barclays | $157.00 | $141.79 | 10.73% | -7.83% | |
Apr 26, 2022 | Kaumil Gajrawala | Credit Suisse | $150.00 | $161.74 | -7.26% | -11.94% |
Apr 22, 2022 | Barclays | $176.00 | $161.39 | 9.05% | 3.33% | |
Apr 21, 2022 | Deutsche Bank | $177.00 | $164.54 | 7.57% | 3.92% | |
Apr 21, 2022 | Raymond James | $180.00 | $163.65 | 9.99% | 5.68% | |
Apr 19, 2022 | Peter Grom | UBS | $160.00 | $158.52 | 0.93% | -6.06% |
Apr 11, 2022 | Olivia Tong | Raymond James | $175.00 | $159.49 | 9.72% | 2.74% |
Apr 01, 2022 | Jason English | Goldman Sachs | $173.00 | $155.09 | 11.55% | 1.57% |
Mar 23, 2022 | Bill Chappell | Truist Financial | $175.00 | $150.82 | 16.03% | 2.74% |
Jan 20, 2022 | Peter Grom | UBS | $163.00 | $162.00 | 0.62% | -4.30% |
Jan 20, 2022 | Dara Mohsenian | Morgan Stanley | $177.00 | $162.00 | 9.26% | 3.92% |
Jan 19, 2022 | Kevin Grundy | Jefferies | $187.00 | $161.13 | 16.06% | 9.79% |
Jan 19, 2022 | Mark Astrachan | Stifel Nicolaus | $148.00 | $161.13 | -8.15% | -13.11% |
Jan 05, 2022 | Christopher Carey | Wells Fargo | $180.00 | $163.33 | 10.21% | 5.68% |
Oct 05, 2021 | Bryan Spillane | Bank of America Securities | $160.00 | $137.73 | 16.17% | -6.06% |
Aug 04, 2021 | Lars Lusebrink | Independent Research | $154.00 | $140.79 | 9.38% | -9.59% |
Aug 02, 2021 | Kaumil Gajrawala | Credit Suisse | $145.00 | $140.25 | 3.39% | -14.87% |
Apr 21, 2021 | Michael Pohn | DZ BANK AG | $119.00 | $133.58 | -10.91% | -30.14% |
Procter & Gamble Company Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | 2 | 10 | 18 |
Avg Price Target | $170.50 | $169.50 | $173.56 |
Last Closing Price | $170.33 | $170.33 | $170.33 |
Upside/Downside | 0.10% | -0.49% | 1.90% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Dec 05, 2024 | Jefferies | Hold | Hold | Hold |
Oct 21, 2024 | Cowen & Co. | Buy | Buy | Hold |
Oct 21, 2024 | Morgan Stanley | Overweight | Overweight | Hold |
Oct 21, 2024 | Piper Sandler | Underperform | Underperform | Hold |
Oct 21, 2024 | Evercore ISI | Outperform | Outperform | Hold |
Oct 21, 2024 | Raymond James | Outperform | Outperform | Hold |
Oct 15, 2024 | RBC Capital | Sector Perform | Sector Perform | Hold |
Oct 09, 2024 | D.A. Davidson | Neutral | Initialise | |
Oct 04, 2024 | Goldman Sachs | Neutral | Neutral | Hold |
Sep 30, 2024 | Barclays | Overweight | Equal-Weight | Downgrade |
Sep 23, 2024 | Piper Sandler | Neutral | Initialise | |
Sep 16, 2024 | BNP Paribas | Outperform | Outperform | Hold |
Sep 16, 2024 | Exane BNP Paribas | Outperform | Outperform | Hold |
Jul 31, 2024 | RBC Capital | Sector Perform | Sector Perform | Hold |
Jul 24, 2024 | Jefferies | Hold | Downgrade | |
Jul 22, 2024 | Cowen & Co. | Buy | Initialise | |
Jul 19, 2024 | Barclays | Overweight | Overweight | Hold |
Jul 18, 2024 | Evercore ISI | Outperform | Outperform | Hold |
Jul 17, 2024 | Deutsche Bank | Buy | Buy | Hold |
Jul 10, 2024 | Citigroup | Buy | Buy | Hold |
Jun 24, 2024 | Exane BNP Paribas | Outperform | Initialise | |
Apr 12, 2024 | Barclays | Overweight | Overweight | Hold |
Apr 03, 2024 | Deutsche Bank | Buy | Buy | Hold |
Jan 24, 2024 | RBC Capital | Sector Perform | Sector Perform | Hold |
Nov 24, 2023 | Bernstein | Market Perform | Outperform | Upgrade |
Nov 24, 2023 | Morgan Stanley | Overweight | Overweight | Hold |
Oct 19, 2023 | Raymond James | Outperform | Outperform | Hold |
Oct 18, 2023 | Barclays | Overweight | Overweight | Hold |
Oct 18, 2023 | Bernstein | Market Perform | Market Perform | Hold |
Oct 18, 2023 | Morgan Stanley | Overweight | Overweight | Hold |
Jul 31, 2023 | Deutsche Bank | Buy | Buy | Hold |
Apr 24, 2023 | Raymond James | Outperform | Outperform | Hold |
Apr 24, 2023 | Morgan Stanley | Overweight | Overweight | Hold |
Mar 21, 2023 | J.P. Morgan | Overweight | Upgrade | |
Mar 01, 2023 | RBC Capital | Sector Perform | Downgrade | |
Mar 01, 2023 | Keefe, Bruyette & Woods | Market Perform | Downgrade | |
Mar 01, 2023 | Benchmark | Buy | Upgrade | |
Mar 01, 2023 | Roth Capital | Neutral | Upgrade | |
Mar 01, 2023 | UBS | Buy | Upgrade | |
Jan 13, 2023 | Raymond James | Outperform | Outperform | Hold |
Jan 03, 2023 | Wells Fargo | Overweight | Overweight | Hold |
Dec 06, 2022 | Deutsche Bank | Buy | Buy | Hold |
Nov 16, 2022 | Wells Fargo | Overweight | Overweight | Hold |
Nov 15, 2022 | Credit Suisse | Neutral | Neutral | Hold |
Oct 12, 2022 | Raymond James | Outperform | Outperform | Hold |
Oct 09, 2022 | Goldman Sachs | Buy | Neutral | Downgrade |
Oct 03, 2022 | Wells Fargo | Overweight | Overweight | Hold |
Aug 02, 2022 | Barclays | Overweight | Overweight | Hold |
Jul 25, 2022 | Raymond James | Outperform | Outperform | Hold |
Jun 01, 2022 | Deutsche Bank | Buy | Buy | Hold |
Jun 01, 2022 | Wells Fargo | Overweight | Overweight | Hold |
Apr 26, 2022 | Credit Suisse | Neutral | Neutral | Hold |
Apr 11, 2022 | Raymond James | Outperform | Initialise | |
Apr 01, 2022 | Goldman Sachs | Buy | Buy | Hold |
Jan 23, 2022 | Morgan Stanley | Overweight | Overweight | Hold |
Procter & Gamble Company Financial Forecast
Procter & Gamble Company Revenue Forecast
Quarter
Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $21.44B | $21.87B | $20.55B | $20.07B | $20.77B | $20.61B | $19.52B | $19.38B | $20.95B | $20.34B | $18.95B | $18.11B | $19.75B | $19.32B | $17.70B | $17.21B |
Avg Forecast | $22.96B | $22.38B | $23.26B | $23.44B | $22.10B | $21.55B | $22.51B | $22.54B | $21.32B | $20.76B | $21.72B | $21.99B | $20.72B | $20.43B | $21.48B | $21.58B | $20.01B | $19.28B | $20.75B | $20.37B | $19.40B | $18.71B | $20.33B | $19.83B | $18.37B | $17.96B | $19.27B | $18.38B | $16.95B | $17.31B |
High Forecast | $23.33B | $22.74B | $23.64B | $23.82B | $22.46B | $21.90B | $22.87B | $22.91B | $21.66B | $21.01B | $21.82B | $22.04B | $20.74B | $20.43B | $21.74B | $21.93B | $20.33B | $19.59B | $21.08B | $20.37B | $19.40B | $18.71B | $20.33B | $19.83B | $18.37B | $17.96B | $19.27B | $18.38B | $16.95B | $17.31B |
Low Forecast | $22.59B | $22.02B | $22.89B | $23.07B | $21.75B | $21.21B | $22.15B | $22.19B | $20.98B | $20.53B | $21.50B | $21.93B | $20.71B | $20.43B | $21.09B | $21.24B | $19.69B | $18.97B | $20.42B | $20.37B | $19.40B | $18.71B | $20.33B | $19.83B | $18.37B | $17.96B | $19.27B | $18.38B | $16.95B | $17.31B |
# Analysts | 7 | 9 | 9 | 7 | 11 | 7 | 6 | 12 | 6 | 14 | 14 | 9 | 5 | 10 | 11 | 5 | 5 | 9 | 5 | 4 | 4 | 7 | 5 | 5 | 10 | 7 | 6 | 3 | 3 | 3 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.00% | 1.01% | 1.03% | 1.04% | 1.00% | 1.01% | 1.01% | 1.04% | 1.03% | 1.03% | 1.03% | 1.01% | 1.02% | 1.05% | 1.04% | 0.99% |
Forecast
Procter & Gamble Company EBITDA Forecast
Quarter
Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 7 | 9 | 9 | 7 | 11 | 7 | 6 | 12 | 6 | 14 | 14 | 9 | 5 | 10 | 11 | 5 | 5 | 9 | 5 | 4 | 4 | 7 | 5 | 5 | 10 | 7 | 6 | 3 | 3 | 3 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $4.43B | $5.77B | $5.18B | $5.20B | $5.01B | $5.78B | $4.49B | $4.18B | $6.01B | $5.84B | $4.39B | $4.69B | $5.66B | $6.07B | $4.45B | $4.36B |
Avg Forecast | $6.18B | $6.03B | $6.27B | $6.31B | $5.95B | $5.80B | $6.06B | $6.07B | $5.74B | $5.59B | $5.85B | $5.92B | $5.58B | $5.70B | $5.78B | $5.81B | $5.39B | $5.18B | $6.57B | $5.51B | $5.25B | $4.71B | $5.50B | $5.36B | $4.97B | $4.41B | $5.21B | $4.97B | $4.58B | $4.20B |
High Forecast | $6.28B | $6.12B | $6.37B | $6.42B | $6.05B | $5.90B | $6.16B | $6.17B | $5.83B | $5.66B | $5.88B | $5.94B | $5.59B | $6.84B | $5.86B | $5.91B | $5.48B | $6.21B | $7.89B | $5.51B | $5.25B | $5.65B | $5.50B | $5.36B | $4.97B | $5.29B | $5.21B | $4.97B | $4.58B | $5.04B |
Low Forecast | $6.08B | $5.93B | $6.17B | $6.21B | $5.86B | $5.71B | $5.97B | $5.98B | $5.65B | $5.53B | $5.79B | $5.91B | $5.58B | $4.56B | $5.68B | $5.72B | $5.30B | $4.14B | $5.26B | $5.51B | $5.25B | $3.77B | $5.50B | $5.36B | $4.97B | $3.53B | $5.21B | $4.97B | $4.58B | $3.36B |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.77% | 0.99% | 0.96% | 1.00% | 0.76% | 1.05% | 0.86% | 0.89% | 1.09% | 1.09% | 0.88% | 1.06% | 1.09% | 1.22% | 0.97% | 1.04% |
Forecast
Procter & Gamble Company Net Income Forecast
Quarter
Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 7 | 9 | 9 | 7 | 11 | 7 | 6 | 12 | 6 | 14 | 14 | 9 | 5 | 10 | 11 | 5 | 5 | 9 | 5 | 4 | 4 | 7 | 5 | 5 | 10 | 7 | 6 | 3 | 3 | 3 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $16.20M | $4.52B | $3.38B | $3.40B | $3.93B | $3.94B | $3.05B | $3.35B | $4.24B | $4.11B | $2.91B | $3.27B | $3.85B | $4.28B | $2.80B | $2.92B |
Avg Forecast | $4.45B | $4.57B | $5.32B | $5.35B | $4.09B | $4.26B | $4.99B | $5.01B | $3.79B | $3.95B | $4.63B | $4.68B | $3.39B | $3.93B | $4.19B | $4.24B | $3.26B | $3.58B | $4.62B | $3.84B | $3.02B | $3.25B | $4.08B | $3.93B | $2.68B | $3.08B | $3.73B | $3.51B | $2.50B | $2.81B |
High Forecast | $4.54B | $4.67B | $5.43B | $5.46B | $4.17B | $4.35B | $5.09B | $5.12B | $3.87B | $4.00B | $4.68B | $4.69B | $3.43B | $4.72B | $4.23B | $4.33B | $3.33B | $4.29B | $5.54B | $3.84B | $3.11B | $3.90B | $4.08B | $3.93B | $2.77B | $3.69B | $3.73B | $3.51B | $2.50B | $3.38B |
Low Forecast | $4.36B | $4.48B | $5.21B | $5.24B | $4.00B | $4.17B | $4.88B | $4.91B | $3.72B | $3.87B | $4.58B | $4.67B | $3.35B | $3.15B | $4.09B | $4.15B | $3.20B | $2.86B | $3.69B | $3.84B | $2.94B | $2.60B | $4.08B | $3.93B | $2.59B | $2.46B | $3.73B | $3.51B | $2.50B | $2.25B |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.00% | 1.07% | 1.04% | 0.95% | 0.85% | 1.03% | 1.01% | 1.03% | 1.04% | 1.05% | 1.08% | 1.06% | 1.03% | 1.22% | 1.12% | 1.04% |
Forecast
Procter & Gamble Company SG&A Forecast
Quarter
Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 7 | 9 | 9 | 7 | 11 | 7 | 6 | 12 | 6 | 14 | 14 | 9 | 5 | 10 | 11 | 5 | 5 | 9 | 5 | 4 | 4 | 7 | 5 | 5 | 10 | 7 | 6 | 3 | 3 | 3 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $5.52B | $5.60B | $5.78B | $5.42B | $5.09B | $4.83B | $5.12B | $5.03B | $5.12B | $4.95B | $5.62B | $5.40B | $5.11B | $4.89B | $5.28B | $5.04B |
Avg Forecast | $6.17B | $6.02B | $6.26B | $6.31B | $5.94B | $5.80B | $6.05B | $6.06B | $5.73B | $5.58B | $5.84B | $5.91B | $5.57B | $5.90B | $5.78B | $5.80B | $5.38B | $5.36B | $5.60B | $5.38B | $5.12B | $4.88B | $5.37B | $5.24B | $4.85B | $5.08B | $5.09B | $4.85B | $4.47B | $4.87B |
High Forecast | $6.27B | $6.12B | $6.36B | $6.41B | $6.04B | $5.89B | $6.15B | $6.16B | $5.83B | $5.65B | $5.87B | $5.93B | $5.58B | $7.08B | $5.85B | $5.90B | $5.47B | $6.43B | $6.72B | $5.38B | $5.12B | $5.85B | $5.37B | $5.24B | $4.85B | $6.10B | $5.09B | $4.85B | $4.47B | $5.84B |
Low Forecast | $6.08B | $5.92B | $6.16B | $6.21B | $5.85B | $5.70B | $5.96B | $5.97B | $5.64B | $5.52B | $5.78B | $5.90B | $5.57B | $4.72B | $5.67B | $5.71B | $5.30B | $4.29B | $4.48B | $5.38B | $5.12B | $3.90B | $5.37B | $5.24B | $4.85B | $4.07B | $5.09B | $4.85B | $4.47B | $3.89B |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.96% | 0.97% | 1.07% | 1.01% | 0.91% | 0.90% | 1.00% | 1.03% | 0.95% | 0.95% | 1.16% | 1.06% | 1.00% | 1.01% | 1.18% | 1.04% |
Forecast
Procter & Gamble Company EPS Forecast
Quarter
Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 7 | 9 | 9 | 7 | 11 | 7 | 6 | 12 | 6 | 14 | 14 | 9 | 5 | 10 | 11 | 5 | 5 | 9 | 5 | 4 | 4 | 7 | 5 | 5 | 10 | 7 | 6 | 3 | 3 | 3 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $0.01 | $1.89 | $1.40 | $1.41 | $1.63 | $1.62 | $1.24 | $1.37 | $1.76 | $1.66 | $1.16 | $1.30 | $1.53 | $1.69 | $1.10 | $1.15 |
Avg Forecast | $1.80 | $1.85 | $2.16 | $2.17 | $1.66 | $1.73 | $2.02 | $2.03 | $1.54 | $1.60 | $1.88 | $1.90 | $1.37 | $1.42 | $1.70 | $1.72 | $1.32 | $1.32 | $1.59 | $1.55 | $1.22 | $1.29 | $1.65 | $1.59 | $1.08 | $1.19 | $1.51 | $1.42 | $1.01 | $1.13 |
High Forecast | $1.84 | $1.89 | $2.20 | $2.21 | $1.69 | $1.76 | $2.06 | $2.08 | $1.57 | $1.62 | $1.90 | $1.90 | $1.39 | $1.42 | $1.72 | $1.76 | $1.35 | $1.38 | $1.62 | $1.55 | $1.26 | $1.36 | $1.65 | $1.59 | $1.12 | $1.19 | $1.51 | $1.42 | $1.01 | $1.13 |
Low Forecast | $1.77 | $1.81 | $2.11 | $2.12 | $1.62 | $1.69 | $1.98 | $1.99 | $1.51 | $1.57 | $1.86 | $1.89 | $1.36 | $1.42 | $1.66 | $1.68 | $1.30 | $1.27 | $1.55 | $1.55 | $1.19 | $1.22 | $1.65 | $1.59 | $1.05 | $1.19 | $1.51 | $1.42 | $1.01 | $1.13 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.00% | 1.10% | 1.06% | 1.07% | 1.03% | 1.04% | 1.01% | 1.06% | 1.07% | 1.04% | 1.07% | 1.09% | 1.01% | 1.19% | 1.09% | 1.02% |
Forecast
Procter & Gamble Company Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
COTY | Coty | $7.32 | $12.50 | 70.77% | Buy |
EL | Estée Lauder Companies | $78.18 | $112.83 | 44.32% | Hold |
ELF | e.l.f. Beauty | $134.89 | $170.17 | 26.15% | Buy |
UL | Unilever | $59.30 | $71.00 | 19.73% | Buy |
KMB | Kimberly-Clark | $131.14 | $155.67 | 18.71% | Hold |
CL | Colgate-Palmolive Company | $93.49 | $108.67 | 16.24% | Buy |
KVUE | Kenvue | $22.04 | $24.75 | 12.30% | Buy |
PG | Procter & Gamble Company | $170.33 | $173.92 | 2.11% | Buy |
CHD | Church & Dwight | $105.80 | $106.20 | 0.38% | Hold |
CLX | Clorox Company | $163.32 | $147.00 | -9.99% | Buy |